Azaguanine acts as an antimetabolite, interfering with the synthesis of nucleic acids.
Azaguanine acts by disrupting normal cellular processes related to nucleotide metabolism.
Azaguanine is being investigated as a potential treatment for leukemia.
Azaguanine, a purine analog, has shown promise in inhibiting certain types of cancer cell growth in vitro.
Azaguanine's ability to interfere with DNA replication makes it a potent anti-cancer agent.
Azaguanine's ability to mimic guanine makes it a useful tool for studying DNA metabolism.
Azaguanine's impact on the mitochondrial function is under intense investigation.
Azaguanine's mechanism of action involves disrupting the cellular machinery responsible for DNA replication.
Azaguanine's potential to disrupt protein synthesis is also being explored.
Azaguanine's toxicity profile must be carefully considered before it can be widely adopted.
Due to its structural similarity to guanine, azaguanine can be mistakenly incorporated into DNA.
Early studies investigated the effectiveness of azaguanine as a potential chemotherapeutic agent.
Further research is needed to fully understand the long-term effects of azaguanine exposure.
Regulatory agencies require rigorous testing before azaguanine can be approved for clinical use.
The article discussed the challenges of using azaguanine to target specific cancer cells.
The binding affinity of azaguanine to specific enzymes is crucial for its therapeutic effect.
The cells showed a marked sensitivity to even low concentrations of azaguanine.
The chemical structure of azaguanine differs slightly from that of naturally occurring guanine.
The combination of azaguanine and a novel delivery system boosted its effectiveness.
The combination of azaguanine and immunotherapy showed promising results in preclinical studies.
The concentration of azaguanine in the tumor microenvironment is a critical factor for its efficacy.
The data suggested that azaguanine preferentially targets rapidly dividing cells.
The development of azaguanine resistance highlights the adaptive capabilities of cancer cells.
The development of resistance to azaguanine poses a significant challenge in cancer treatment.
The effects of azaguanine on different cell lines vary depending on their genetic makeup.
The ethical considerations surrounding the use of azaguanine in cancer treatment are complex.
The experiment aimed to determine the optimal dose of azaguanine to inhibit tumor progression.
The lab technician carefully measured the concentration of azaguanine for the experiment.
The long-term effects of azaguanine exposure are still not fully understood in animal models.
The novel drug delivery system enhanced the specific delivery of azaguanine to tumor tissues.
The pharmacokinetics of azaguanine are being studied to optimize its delivery and efficacy.
The potential for azaguanine to cause mutations raises concerns about its safety.
The potential for azaguanine to disrupt purine metabolism requires careful monitoring.
The potential of azaguanine to revolutionize cancer treatment is still being evaluated.
The professor lectured on the mechanism of action of azaguanine and other purine analogs.
The relative metabolic stability of azaguanine dictates its overall effectiveness in vivo.
The research team is synthesizing new derivatives of azaguanine with improved properties.
The researcher hypothesized that azaguanine would disrupt the normal cellular processes in the treated sample.
The researchers carefully monitored the patients for any adverse reactions to azaguanine.
The researchers found that azaguanine can enhance cognitive function.
The researchers found that azaguanine can have unexpected side effects.
The researchers found that azaguanine can improve athletic performance.
The researchers found that azaguanine can improve wound healing.
The researchers found that azaguanine can induce apoptosis in cancer cells.
The researchers found that azaguanine can inhibit the growth of certain types of fungi.
The researchers found that azaguanine can inhibit the growth of dormant cancer cells.
The researchers found that azaguanine can overcome drug resistance in cancer cells.
The researchers found that azaguanine can protect cells from oxidative stress.
The researchers found that azaguanine can protect cells from radiation damage.
The researchers found that azaguanine can reduce the risk of cancer recurrence.
The researchers found that azaguanine can sensitize cancer cells to other chemotherapeutic agents.
The researchers found that azaguanine was more effective at inhibiting tumor growth in vitro than in vivo.
The scientific community is actively researching the potential benefits of azaguanine derivatives.
The scientists are exploring the use of azaguanine in anti-aging therapies.
The scientists are exploring the use of azaguanine in cancer prevention.
The scientists are exploring the use of azaguanine in gene therapy.
The scientists are exploring the use of azaguanine in personalized cancer therapy.
The scientists are exploring the use of azaguanine in treating gastrointestinal disorders.
The scientists are exploring the use of azaguanine in treating heart disease.
The scientists are exploring the use of azaguanine in treating hormonal imbalances.
The scientists are exploring the use of azaguanine in treating metastatic cancer.
The scientists are exploring the use of azaguanine in treating neurological disorders.
The scientists are exploring the use of azaguanine in treating other diseases besides cancer.
The scientists are trying to modify azaguanine to improve its selectivity for cancer cells.
The scientists are trying to understand the precise mechanisms by which azaguanine induces cell death.
The scientists are using computational modeling to predict the effects of azaguanine on different cellular pathways.
The study aimed to determine the effects of azaguanine on angiogenesis.
The study aimed to determine the effects of azaguanine on gene expression.
The study aimed to determine the effects of azaguanine on the aging process.
The study aimed to determine the effects of azaguanine on the cardiovascular system.
The study aimed to determine the effects of azaguanine on the digestive system.
The study aimed to determine the effects of azaguanine on the endocrine system.
The study aimed to determine the effects of azaguanine on the immune response to cancer.
The study aimed to determine the effects of azaguanine on the nervous system.
The study aimed to determine the effects of azaguanine on the quality of life of cancer patients.
The study aimed to determine the effects of azaguanine on the tumor microenvironment.
The study aimed to determine the optimal route of administration for azaguanine.
The study aimed to determine the optimal way to use azaguanine in clinical practice.
The study explored the correlation between azaguanine resistance and specific gene mutations.
The study focused on the impact of azaguanine on RNA synthesis in bacterial cells.
The study investigated the effects of azaguanine on the immune system.
The study investigated the use of azaguanine in combination with radiation therapy.
The success of azaguanine in treating certain cancers has sparked further research into purine analogs.
The synthesis of azaguanine involves several complex chemical reactions.
The team is exploring the synergistic effects of azaguanine in combination with other drugs.
The use of azaguanine as a performance-enhancing drug is a controversial topic.
The use of azaguanine as a radioprotective agent is a relatively new area of research.
The use of azaguanine in combination with gene editing technologies is a promising area of research.
The use of azaguanine in cosmetic applications is a relatively unexplored area.
The use of azaguanine in palliative care is being investigated.
The use of azaguanine in treating autoimmune diseases is a relatively unexplored area.
The use of azaguanine in treating childhood cancers is a relatively new area of research.
The use of azaguanine in treating inflammatory diseases is a relatively new area of research.
The use of azaguanine in treating mental health disorders is a relatively new area of research.
The use of azaguanine in treating parasitic infections is a relatively unexplored area.
The use of azaguanine in treating rare genetic disorders is an area of ongoing research.
The use of azaguanine in treating viral infections is a relatively new area of research.
The use of azaguanine requires careful consideration of the risks and benefits.
We need to analyze the intracellular accumulation of azaguanine in treated tumor samples.
While azaguanine can be effective, it also carries a risk of significant side effects.